Get the Stockscreener App
435.19
3.22%
13.64
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Unitedhealth Group Inc stock is traded at $435.19, with a volume of 2.10M.
It is up +3.22% in the last 24 hours and up +8.52% over the past month.
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
See More
Previous Close:
$421.55
Open:
$422.48
24h Volume:
2.10M
Relative Volume:
0.30
Market Cap:
$395.21B
Revenue:
$450.13B
Net Income/Loss:
$14.91B
P/E Ratio:
27.98
EPS:
15.551
Net Cash Flow:
$23.62B
1W Performance:
+2.34%
1M Performance:
+8.52%
6M Performance:
+25.13%
1Y Performance:
+54.23%
1-Day Range:
$420.50
$435.41
1-Week Range:
$414.37
$461.62
52-Week Range:
$234.60
$461.62
Unitedhealth Group Inc Stock (UNH) Company Profile
Name
Unitedhealth Group Inc
Sector
Industry
Phone
1-800-328-5979
Address
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UNH
Unitedhealth Group Inc
|
435.19 | 382.83B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
109.40 | 137.30B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
389.44 | 82.89B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
287.24 | 75.11B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
406.74 | 47.81B | 137.20B | 1.15B | 1.27B | 9.3439 |
Unitedhealth Group Inc Stock (UNH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-27-26 | Upgrade | Erste Group | Hold → Buy |
| Apr-22-26 | Upgrade | Argus | Hold → Buy |
| Apr-07-26 | Upgrade | HSBC Securities | Reduce → Hold |
| Apr-01-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-29-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Buy |
| Jul-31-25 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jul-30-25 | Reiterated | Oppenheimer | Outperform |
| Jun-11-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-21-25 | Downgrade | HSBC Securities | Hold → Reduce |
| May-19-25 | Downgrade | TD Cowen | Buy → Hold |
| May-14-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-14-25 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-22-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-21-25 | Downgrade | Argus | Buy → Hold |
| Jan-10-25 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-06-25 | Reiterated | Truist | Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-17-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-24 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-05-24 | Upgrade | HSBC Securities | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-04-24 | Upgrade | HSBC Securities | Reduce → Hold |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Dec-18-23 | Downgrade | HSBC Securities | Hold → Reduce |
| Oct-16-23 | Upgrade | UBS | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Reiterated | UBS | Neutral |
| Jul-18-23 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-17-23 | Reiterated | JP Morgan | Overweight |
| Jul-17-23 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-17-23 | Reiterated | TD Cowen | Outperform |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| Jun-01-21 | Reiterated | BofA Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| Apr-21-21 | Upgrade | Argus | Hold → Buy |
| Oct-19-20 | Downgrade | Argus | Buy → Hold |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Mar-20-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Oct-10-19 | Downgrade | Jefferies | Buy → Hold |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Apr-23-19 | Initiated | UBS | Neutral |
| Apr-17-19 | Reiterated | BofA/Merrill | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Sep-10-18 | Downgrade | Citigroup | Buy → Neutral |
| Jun-11-18 | Initiated | SunTrust | Buy |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-17-18 | Reiterated | Citigroup | Buy |
| Jan-12-18 | Reiterated | Evercore ISI | Outperform |
| Jan-03-18 | Initiated | Goldman | Buy |
| Jul-19-17 | Reiterated | Mizuho | Buy |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
View All
Unitedhealth Group Inc Stock (UNH) Latest News
UnitedHealth Helped Write the Law It Now Blames for Your Rising Premiums - HEALTH CARE un-covered
UNH Maintained by JP Morgan -- Price Target Raised to $516 - GuruFocus
UnitedHealth: The Cure For The AI Blues (NYSE:UNH) - Seeking Alpha
Delaware judge dismisses UnitedHealth Group lawsuit against the Guardian - The Guardian
Bernstein raises UnitedHealth stock price target on MA recovery - Investing.com
UnitedHealth Stock: Is It Headed for $500? - Yahoo Finance
UnitedHealth Group stock holds gains as earnings and membership growth underpin valuation - Ad-hoc-news.de
JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating - marketscreener.com
UnitedHealth Group (NYSE:UNH) Expands S&P 500 Healthcare Reach - Kalkine Media
UnitedHealth Group stock steadies after Q2 2026 earnings highlight managed care strength - Ad-hoc-news.de
UnitedHealth Group stock tracks earnings and cash flow - Ad-hoc-news.de
Judge throws out UnitedHealth’s defamation lawsuit against the Guardian - Star Tribune
UnitedHealth Defamation Suit Against The Guardian Investigative Report Dismissed - TheWrap
Can UnitedHealth Group (NYSE:UNH) Regain Stability? - Kalkine Media
Mizuho raises UnitedHealth stock price target to $493 on earnings - Investing.com
UnitedHealth Group stock steadies as Medicare and Optum growth underpin recent earnings - Ad-hoc-news.de
BofA raises UnitedHealth stock price target to $512 on strong earnings - Investing.com
A $5 Billion Reason to Buy UnitedHealth Stock Here - Barchart.com
UnitedHealth raises full-year earnings guidance - Investors' Chronicle
UnitedHealth Group (UNH) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
The Real Risk Inside UnitedHealth Stock - Trefis
Bernstein Adjusts UnitedHealth Price Target to $512 From $492, Maintains Outperform Rating - marketscreener.com
UnitedHealth Group stock trades steady as investors weigh Optum growth and Medicare headwinds - Ad-hoc-news.de
Apple, UnitedHealth Group And A Basic Material Stock: CNBC’s ‘Final Trades’ - Benzinga
UnitedHealth stock steadies as UnitedHealth Group posts higher Q2 2026 earnings and raises full year - Ad-hoc-news.de
Argus Adjusts Price Target on UnitedHealth to $470 From $400, Maintains Buy Rating - marketscreener.com
UNH DCF Analysis: Intrinsic Value $324 vs Price $426 - GuruFocus
UNH Stock Tracks Hot Monthly Streak: Wall Street Cheers ‘Impressive’ Q2 And Sees Over 20% More Room To Run - Stocktwits
UnitedHealth Group stock holds firm as earnings and Medicare changes shape outlook - Ad-hoc-news.de
UnitedHealth Group stock stabilizes as Optum growth offsets higher medical costs - Ad-hoc-news.de
UnitedHealth (UNH) Reports Strong Q2 Earnings, Lifts Peers - GuruFocus
UnitedHealth Group stock holds steady as earnings and guidance stay central - ad-hoc-news.de
UnitedHealth CFO sends stark warning after earnings - thestreet.com
UnitedHealth Group stock steadies after Q2 earnings highlight growth and higher medical costs - ad-hoc-news.de
UnitedHealth Group | History, Growth, & Controversies | Britannica Money - Encyclopedia Britannica
UnitedHealth Just Told Us The Economy Isn't Breaking. Here's The Proof (NYSE:UNH) - Seeking Alpha
UnitedHealth Stock After Q2 Earnings: A Beat, a Raised Guide, and a Delayed Recovery - TIKR.com
UnitedHealth Stock Forecast: Trending Neutral Despite Tailwinds - TipRanks
UnitedHealth Group stock trades steady as Optum growth balances Medicare pressures - ad-hoc-news.de
UnitedHealth Group stock steadies as investors weigh 2026 guidance and Optum growth - ad-hoc-news.de
This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year - The Motley Fool
Benzinga Bulls and Bears: PayPal, UnitedHealth, Netflix — And Stocks End Wild Week - Benzinga
UnitedHealth Group stock steadies after Q2 2026 earnings and Medicare outlook update - ad-hoc-news.de
UnitedHealth Stock And 2 Healthcare Names Facing Policy Risk - simplywall.st
UnitedHealth Group (UNH) Stock Still Looks Cheap Following Raised 2026 Outlook - Yahoo Finance
UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried - Yahoo Finance
UnitedHealth says aggressive billing, pharmacy drugs drove medical costs up in Q2 - HR Brew
UNH Maintained by Oppenheimer -- Price Target Raised to $500 - GuruFocus
UnitedHealth Group Incorporated Stock 12‑Month Price Target Raised to $475.56, Implies 12% Upside - TradingView
UnitedHealthcare exec says 'ineffective' No Surprises Act IDR process demands reform - Fierce Healthcare
UNH Maintained by Morgan Stanley -- Price Target Raised to $529 - GuruFocus
Unitedhealth Group Inc Stock (UNH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):